Priya Pillutla
Adult Congenital Heart Disease · Los Angeles, CANPI 1255453171
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations.
Across 153 payments — averaging $25.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actelion Pharmaceuticals US, Inc.$890
- Boston Scientific$669
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$333
- Shockwave Medical, Inc$223
- Pfizer$200
- Edwards Lifesciences$187
- plus $1K from 19 others
Across 26 payments — averaging $4464.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$114K
- Janssen Research & Development, LLC$2K
What the payments were for
- Food & beverage$3,974100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 41 | $890 |
| Boston Scientific | 36 | $669 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $333 |
| Shockwave Medical, Inc | 1 | $223 |
| Pfizer | 11 | $200 |
| Edwards Lifesciences | 1 | $187 |
| Inspire Medical Systems, Inc. | 1 | $179 |
| Johnson & Johnson | 7 | $169 |
| E.r. Squibb & Sons, L.L.C. | 7 | $153 |
| Cvrx, Inc. | 1 | $143 |
| Novartis | 5 | $121 |
| Amgen | 4 | $112 |
| Astellas Pharma US Inc | 5 | $103 |
| Boehringer Ingelheim | 3 | $95 |
| Scpharmaceuticals Inc. | 3 | $60 |
| Lantheus Medical Imaging, Inc. | 2 | $59 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $49 |
| Abbott | 2 | $44 |
| Novo Nordisk | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| United Therapeutics Corporation | 1 | $30 |
| Medtronic | 1 | $28 |
| Philips North America LLC | 1 | $20 |
| AstraZeneca | 1 | $19 |
| Teleflex LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few adult congenital heart disease providers in Californiato place this figure against a meaningful peer group, so we don't.
Other adult congenital heart disease in Los Angeles
- Prashanth VenkateshLos Angeles$3K
- David LaughrunLos Angeles$101
- Taylor HolveSanta Barbara$15K
- Angela LiOrange$8K
- Ahmed KheiwaLoma Linda$5K
- Ramesh BansalLoma Linda$2K
- Padmini VaradarajanRedlands$1K
- Karen SchultzSacramento$825
- Jeannette LinOrange$569
- Daniel ClarkStanford$311
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.